Princeton Global Asset Management LLC Seagen Inc. Transaction History

Princeton Global Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	BUY	$142.45 - $169.82 $10,968 - $13,076	77 Added 481.25%	93 $16,000
Q3 2021 Nov 03, 2021	SELL	$142.45 - $169.82 $10,968 - $13,076	-77 Reduced 82.8%	16 $16,000
Q3 2020 Oct 27, 2020	BUY	$145.95 - $195.69 $13,573 - $18,199	93 New	93 $18,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.